- Report
- November 2020
- 112 Pages
Italy
From €3819EUR$3,995USD£3,282GBP
- Report
- November 2020
- 112 Pages
France
From €3819EUR$3,995USD£3,282GBP
- Report
- November 2020
- 112 Pages
United Kingdom
From €3819EUR$3,995USD£3,282GBP
- Report
- November 2020
- 110 Pages
Mexico
From €3819EUR$3,995USD£3,282GBP
- Report
- March 2024
- 132 Pages
Global
From €908EUR$950USD£780GBP
- Report
- July 2021
- 11 Pages
Global
From €2868EUR$3,000USD£2,465GBP
- Report
- February 2022
- 142 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- February 2024
- 140 Pages
Vietnam
From €3536EUR$3,699USD£3,039GBP
The Vascular Closure Device (VCD) market is a segment of the Cardiovascular Devices industry. VCDs are used to close the puncture site of a vessel after a catheterization procedure. They are designed to reduce the risk of bleeding and hematoma formation, and to reduce the time required for the patient to recover. VCDs are typically made of biocompatible materials such as polymers, metals, and fabrics.
VCDs are used in a variety of cardiovascular procedures, including angioplasty, stenting, and atherectomy. They are also used in the treatment of peripheral artery disease, coronary artery disease, and other cardiovascular conditions.
The VCD market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Medtronic, Terumo, Merit Medical, and Boston Scientific. Show Less Read more